These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 49112)

  • 41. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical significance of the combined determination of alpha 1 fetoprotein, lipoprotein X, and hepatitis B antigen and antibodies].
    Weiss W; Kroiss A; Benko H; Neumayr A; Eder G
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1765-9. PubMed ID: 73218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute viral hepatitis in Papua New Guinea: results of hepatitis B antigen and antibody studies.
    Woodfield DG
    Trop Geogr Med; 1975 Dec; 27(4):399-404. PubMed ID: 1216321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Light-microscopy demonstration of HB-Ag in liver biopsies. Comparative studies on HB-Ag findings in the serum with results of aldehyde-thionine staining].
    Vogel HM; Henning H; Lüders CJ; von Braun HH; Tripatzis I
    Z Gastroenterol; 1974 Jun; 12(4):257-64. PubMed ID: 4139830
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hepatitis-B-surface-antibodies (detection, incidence, clinical importance)].
    Pesendorfer FX
    Wien Klin Wochenschr Suppl; 1976; 57():1-22. PubMed ID: 1069404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of HB virus infection in an area of Japan with high incidence of liver cirrhosis and hepatocellular carcinoma: an analysis of consecutive studies among inhabitants of Tomié-Town, Goto Islands.
    Munehisa T; Nakata K; Fukahori A; Muro T; Kono K; Furukawa R; Kusumoto Y; Iwanaga A; Ishii N; Koji T
    Am J Gastroenterol; 1984 Aug; 79(8):633-6. PubMed ID: 6087656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia.
    Wu JC; Daughaday WH; Lee SD; Hsiao TS; Chou CK; Lin HD; Tsai YT; Chiang BN
    J Lab Clin Med; 1988 Nov; 112(5):589-94. PubMed ID: 2460570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
    Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
    Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes.
    Tsega E; Nordenfelt E; Hansson BG; Mengesha B; Lindberg J
    Ethiop Med J; 1992 Apr; 30(2 Suppl):1-33. PubMed ID: 1319901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [HB-antigenemia and liver pathology].
    Bliuger AF; Kartashova OIa
    Arkh Patol; 1978; 40(3):81-7. PubMed ID: 77157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary liver cancer, alpha1 fetoprotein and hepatitis B antigen in Papua New Guinea.
    Woodfield DG; Endo Y; Matsuhashi T
    Aust N Z J Med; 1974 Feb; 4(1):3-7. PubMed ID: 4135927
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatitis B surface antigen and liver cell carcinoma.
    Williams AO
    Am J Med Sci; 1975; 270(1):53-6. PubMed ID: 53011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.
    Reed WD; Stern RB; Eddleston AL; Williams R; Zuckerman AJ; Bowes A; Earl PM
    Lancet; 1973 Sep; 2(7831):690-4. PubMed ID: 4125788
    [No Abstract]   [Full Text] [Related]  

  • 55. Hepatocellular carcinoma: relation to alcohol, HB-antigen and alpha-fetoprotein.
    Dourdourekas D; Villa F; Szanto PB; Steigmann F
    Am J Gastroenterol; 1975 Apr; 63(4):307-11. PubMed ID: 48339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha-Fetoprotein and hepatitis B antigen in hepatoma and hepatitis.
    Ichida F; Shibasaki K
    Ann N Y Acad Sci; 1975 Aug; 259():259-60. PubMed ID: 54029
    [No Abstract]   [Full Text] [Related]  

  • 57. [Carcinofetal antigens. I. alpha-fetoprotein (author's transl)].
    Lamerz R; Fateh-Moghadam A
    Klin Wochenschr; 1975 Feb; 53(4):147-69. PubMed ID: 164580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. alpha-Fetoprotein in liver disease.
    Alexander MG; Purves LR; Kirsch RE; Bass NM; Gitlin N; Terblanche J; Saunders SJ
    S Afr Med J; 1978 Mar; 53(12):433-6. PubMed ID: 79225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The spectrum of liver disease in the United Arab Emirates.
    Bate CM; Wolstenholme RJ; Moffatt AD
    Trans R Soc Trop Med Hyg; 1981; 75(4):570-2. PubMed ID: 6275580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Frequency of Australia antigen in the hospital population and in the course of cirrhosis and liver cancers in African patients in Dakar].
    Sankalé M; Seck I
    Bull Soc Pathol Exot Filiales; 1971; 64(6):821-7. PubMed ID: 5005248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.